​

Funding Round

Series E - Obalon Therapeutics

Series E - Obalon Therapeutics

Investment Firm

Overview

Obalon Therapeutics offers gastric balloon technology that assists weight loss.

Announced Date

May 01, 2016

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorBader Sultan & Brothers
Participant InvestorInterWest Partners
Participant InvestorDomain Associates
Participant InvestorOkapi Venture Capital

Round Details and Background

Obalon Therapeutics raised $15800000 on 2016-05-01 in Series E

Obalon Therapeutics offers gastric balloon technology that assists weight loss.

Company Funding History

13

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 02, 2014
Venture Round - Obalon Therapeutics
-15.9M
Mar 26, 2012
Debt Financing - Obalon Therapeutics
-1.5M
Dec 19, 2012
Venture Round - Obalon Therapeutics
1-5.0M
Jul 18, 2012
Series C - Obalon Therapeutics
3-16.5M

Recent Activity

There is no recent news or activity for this profile.